Immune checkpoint proteins: a focus on PD-1/PD-L1
Frontiers | Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice | Immunology
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer | Oncology
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment - Pawłowska - 2019 - Clinical & Experimental Immunology - Wiley Online Library
Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives - Cancer Treatment Reviews
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms - Annals of Oncology
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
PD-L1 | Journal of Clinical Pathology
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - National Cancer Institute
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Cancers | Free Full-Text | PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review | HTML
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors | Cell and Developmental Biology
PD-1/PD-L1 mechanism of action. Key: MHC, major histocompatibility;... | Download Scientific Diagram
PD-1/PD-L1 Blockade for Cancer Therapy - Creative Biolabs
The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives | Porto Biomedical Journal
PD-1/PD-L1, What a Powerful Immune Checkpoint-CUSABIO
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therap | DDDT
Revisiting the PD-1 pathway
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
